 Jordan Abbott
Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Common Variable Immunodeficiency | 2 | 2022 | 30 | 1.230 |
Why?
| | Immunoglobulin Class Switching | 1 | 2025 | 21 | 0.910 |
Why?
| | Immune System Diseases | 1 | 2025 | 40 | 0.890 |
Why?
| | Germinal Center | 1 | 2025 | 63 | 0.880 |
Why?
| | Job Syndrome | 1 | 2023 | 7 | 0.820 |
Why?
| | Chromosome Disorders | 1 | 2023 | 43 | 0.820 |
Why?
| | Immunologic Deficiency Syndromes | 2 | 2020 | 72 | 0.780 |
Why?
| | Mutation | 8 | 2023 | 3994 | 0.750 |
Why?
| | B-Lymphocytes | 2 | 2025 | 849 | 0.740 |
Why?
| | Genetic Diseases, Inborn | 1 | 2022 | 44 | 0.740 |
Why?
| | Intellectual Disability | 1 | 2023 | 165 | 0.730 |
Why?
| | Immunoglobulins, Intravenous | 2 | 2022 | 129 | 0.720 |
Why?
| | Autistic Disorder | 1 | 2023 | 205 | 0.680 |
Why?
| | I-kappa B Kinase | 1 | 2020 | 54 | 0.660 |
Why?
| | Polyendocrinopathies, Autoimmune | 1 | 2017 | 18 | 0.550 |
Why?
| | Agammaglobulinemia | 2 | 2013 | 34 | 0.510 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2013 | 24 | 0.410 |
Why?
| | Open Reading Frames | 1 | 2013 | 132 | 0.390 |
Why?
| | Pedigree | 4 | 2020 | 511 | 0.340 |
Why?
| | Heterozygote | 3 | 2020 | 305 | 0.330 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2013 | 424 | 0.330 |
Why?
| | Quality of Life | 1 | 2022 | 2936 | 0.320 |
Why?
| | Transcription Factors | 1 | 2017 | 1709 | 0.310 |
Why?
| | Lung | 1 | 2020 | 4065 | 0.260 |
Why?
| | Lymphopenia | 2 | 2019 | 64 | 0.260 |
Why?
| | Humans | 22 | 2025 | 138102 | 0.220 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2023 | 36 | 0.210 |
Why?
| | Immunoglobulin A | 1 | 2025 | 213 | 0.200 |
Why?
| | Chromosome Deletion | 1 | 2023 | 114 | 0.200 |
Why?
| | Immunologic Memory | 1 | 2025 | 358 | 0.190 |
Why?
| | Neuromuscular Diseases | 1 | 2024 | 132 | 0.180 |
Why?
| | Immunoglobulins | 1 | 2022 | 169 | 0.180 |
Why?
| | Genetic Therapy | 1 | 2024 | 310 | 0.180 |
Why?
| | STAT3 Transcription Factor | 1 | 2023 | 203 | 0.180 |
Why?
| | Immunoglobulin E | 1 | 2023 | 325 | 0.180 |
Why?
| | Immunity | 1 | 2022 | 141 | 0.180 |
Why?
| | Immunophenotyping | 1 | 2022 | 324 | 0.170 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2022 | 98 | 0.170 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2017 | 3664 | 0.170 |
Why?
| | Cholesterol Side-Chain Cleavage Enzyme | 1 | 2020 | 9 | 0.170 |
Why?
| | Immunoglobulin G | 1 | 2025 | 901 | 0.170 |
Why?
| | Fatal Outcome | 1 | 2020 | 309 | 0.160 |
Why?
| | Interleukin-13 | 1 | 2020 | 148 | 0.150 |
Why?
| | Th2 Cells | 1 | 2020 | 179 | 0.150 |
Why?
| | DNA Ligase ATP | 1 | 2018 | 4 | 0.150 |
Why?
| | Bronchiectasis | 1 | 2020 | 110 | 0.150 |
Why?
| | Forkhead Transcription Factors | 1 | 2019 | 201 | 0.140 |
Why?
| | HEK293 Cells | 2 | 2018 | 730 | 0.140 |
Why?
| | Flow Cytometry | 1 | 2022 | 1194 | 0.140 |
Why?
| | Thymus Gland | 1 | 2019 | 314 | 0.140 |
Why?
| | Peanut Hypersensitivity | 1 | 2020 | 146 | 0.140 |
Why?
| | Colitis | 1 | 2021 | 267 | 0.140 |
Why?
| | Loss of Function Mutation | 1 | 2017 | 46 | 0.140 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2017 | 22 | 0.130 |
Why?
| | Guanylate Cyclase | 1 | 2017 | 37 | 0.130 |
Why?
| | Interferon-Induced Helicase, IFIH1 | 1 | 2017 | 18 | 0.130 |
Why?
| | Longitudinal Studies | 1 | 2025 | 2861 | 0.130 |
Why?
| | Protein Conformation | 1 | 2020 | 944 | 0.130 |
Why?
| | Rhinovirus | 1 | 2017 | 57 | 0.130 |
Why?
| | Hyper-IgM Immunodeficiency Syndrome | 1 | 2016 | 2 | 0.130 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1239 | 0.130 |
Why?
| | Picornaviridae Infections | 1 | 2017 | 50 | 0.130 |
Why?
| | Respiratory Insufficiency | 1 | 2020 | 317 | 0.130 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2021 | 350 | 0.130 |
Why?
| | Germ-Line Mutation | 1 | 2017 | 171 | 0.120 |
Why?
| | Protein Domains | 1 | 2017 | 289 | 0.120 |
Why?
| | Male | 11 | 2025 | 67984 | 0.120 |
Why?
| | T-Lymphocytes | 3 | 2019 | 1983 | 0.120 |
Why?
| | Hemorrhage | 1 | 2020 | 719 | 0.120 |
Why?
| | Alleles | 1 | 2018 | 888 | 0.120 |
Why?
| | Polymorphism, Genetic | 1 | 2017 | 635 | 0.110 |
Why?
| | Severe Combined Immunodeficiency | 1 | 2014 | 20 | 0.110 |
Why?
| | Child, Preschool | 6 | 2020 | 11142 | 0.110 |
Why?
| | Cytokines | 1 | 2022 | 2079 | 0.110 |
Why?
| | Diagnosis, Differential | 2 | 2015 | 1490 | 0.110 |
Why?
| | Registries | 1 | 2022 | 2059 | 0.100 |
Why?
| | Dermatitis, Atopic | 1 | 2017 | 329 | 0.100 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 65 | 0.100 |
Why?
| | Cerebrovascular Disorders | 1 | 2014 | 96 | 0.100 |
Why?
| | Neonatal Screening | 1 | 2014 | 167 | 0.100 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 307 | 0.100 |
Why?
| | Adult | 4 | 2025 | 38063 | 0.090 |
Why?
| | Autoimmunity | 1 | 2017 | 899 | 0.090 |
Why?
| | Genetic Association Studies | 1 | 2013 | 373 | 0.090 |
Why?
| | Disease Management | 1 | 2015 | 620 | 0.090 |
Why?
| | DNA Mutational Analysis | 3 | 2017 | 398 | 0.090 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2016 | 625 | 0.090 |
Why?
| | Herpesvirus 3, Human | 1 | 2014 | 331 | 0.080 |
Why?
| | Retrospective Studies | 3 | 2025 | 15750 | 0.080 |
Why?
| | Herpes Zoster | 1 | 2014 | 314 | 0.080 |
Why?
| | Aged | 2 | 2025 | 23995 | 0.070 |
Why?
| | Middle Aged | 3 | 2025 | 33509 | 0.060 |
Why?
| | Female | 7 | 2025 | 73648 | 0.060 |
Why?
| | NF-kappa B | 2 | 2022 | 679 | 0.060 |
Why?
| | Phenotype | 1 | 2013 | 3158 | 0.060 |
Why?
| | Lymphocyte Activation | 2 | 2020 | 1146 | 0.060 |
Why?
| | Adolescent | 3 | 2020 | 21637 | 0.050 |
Why?
| | Muscular Dystrophies | 1 | 2024 | 36 | 0.050 |
Why?
| | Autophagy-Related Proteins | 1 | 2022 | 46 | 0.050 |
Why?
| | Hyperplasia | 1 | 2022 | 176 | 0.050 |
Why?
| | Vesicular Transport Proteins | 1 | 2022 | 85 | 0.050 |
Why?
| | Herpesvirus 4, Human | 1 | 2022 | 165 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 235 | 0.040 |
Why?
| | Haploinsufficiency | 1 | 2021 | 56 | 0.040 |
Why?
| | CTLA-4 Antigen | 1 | 2021 | 98 | 0.040 |
Why?
| | Aminoglutethimide | 1 | 2020 | 5 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 118 | 0.040 |
Why?
| | Autophagy | 1 | 2022 | 286 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 568 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 368 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2020 | 818 | 0.040 |
Why?
| | Young Adult | 3 | 2020 | 13329 | 0.030 |
Why?
| | Transfection | 1 | 2020 | 938 | 0.030 |
Why?
| | Amino Acid Transport System ASC | 1 | 2017 | 12 | 0.030 |
Why?
| | Genes, Dominant | 1 | 2017 | 97 | 0.030 |
Why?
| | Jurkat Cells | 1 | 2017 | 138 | 0.030 |
Why?
| | Genes, Recessive | 1 | 2017 | 78 | 0.030 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2017 | 47 | 0.030 |
Why?
| | Glutamine | 1 | 2017 | 104 | 0.030 |
Why?
| | Homozygote | 1 | 2017 | 203 | 0.030 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 126 | 0.030 |
Why?
| | Time | 1 | 2016 | 88 | 0.030 |
Why?
| | Cohort Studies | 2 | 2017 | 5731 | 0.030 |
Why?
| | Multiprotein Complexes | 1 | 2017 | 165 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2022 | 1154 | 0.030 |
Why?
| | Interferons | 1 | 2017 | 203 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2019 | 6140 | 0.030 |
Why?
| | Cell Line | 1 | 2020 | 2865 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 878 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2017 | 414 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2017 | 376 | 0.030 |
Why?
| | Infant | 2 | 2019 | 9566 | 0.030 |
Why?
| | Base Sequence | 1 | 2017 | 2180 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2016 | 1265 | 0.020 |
Why?
| | Child | 3 | 2020 | 21990 | 0.020 |
Why?
| | Genetic Counseling | 1 | 2013 | 79 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2020 | 2799 | 0.020 |
Why?
| | Gene Expression | 1 | 2017 | 1487 | 0.020 |
Why?
| | Fibroblasts | 1 | 2017 | 1002 | 0.020 |
Why?
| | Antiviral Agents | 1 | 2017 | 759 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1292 | 0.020 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2014 | 718 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4160 | 0.020 |
Why?
| | Incidence | 1 | 2014 | 2827 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2016 | 5144 | 0.020 |
Why?
| | Prognosis | 1 | 2014 | 3982 | 0.020 |
Why?
| | Mice | 1 | 2019 | 17769 | 0.010 |
Why?
| | Brain | 1 | 2014 | 2725 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3608 | 0.010 |
Why?
| | Animals | 1 | 2019 | 37151 | 0.010 |
Why?
| | United States | 1 | 2014 | 15028 | 0.010 |
Why?
|
|
Abbott's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|